About conolidine
Andy Chevigné and his workforce, RTI-5152-12 is postulated to enhance the levels of opioid peptides that bind to classical opioid receptors during the Mind, leading to heightened painkilling activity. The LIH-RTI study groups founded a collaboration agreement and filed a joint patent software in December 2020.Prior to we progress any additional us